TRUHANCIS Trademark

Trademark Overview

On Friday, December 9, 2011, a trademark application was filed for TRUHANCIS with the United States Patent and Trademark Office. The USPTO has given the TRUHANCIS trademark a serial number of 79110199. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, March 28, 2019. This trademark is owned by H. Lundbeck A/S. The TRUHANCIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants: pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and chemical addiction; diagnostic preparations, substances, reagents and agents for medical purposes
truhancis

General Information

Serial Number79110199
Word MarkTRUHANCIS
Filing DateFriday, December 9, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, March 28, 2019
Registration Number4307200
Registration DateTuesday, March 26, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of disorders and diseases affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants: pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and chemical addiction; diagnostic preparations, substances, reagents and agents for medical purposes
Translation of Words in MarkThe wording "TRUHANCIS" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, March 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK-2500 VALBY
DK
Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK-2500 VALBY
DK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK-2500 VALBY
DK

Trademark Events

Event DateEvent Description
Friday, April 12, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, April 12, 2019DEATH OF INTERNATIONAL REGISTRATION
Monday, March 26, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, June 12, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 12, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, July 14, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 27, 2013FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 27, 2013FINAL DISPOSITION PROCESSED
Wednesday, June 26, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 26, 2013REGISTERED-PRINCIPAL REGISTER
Friday, February 8, 2013NOTIFICATION PROCESSED BY IB
Tuesday, January 8, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 19, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 4, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 29, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2012EXAMINER'S AMENDMENT ENTERED
Thursday, November 29, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2012EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 23, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 23, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 17, 2012ASSIGNED TO LIE
Thursday, October 4, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 15, 2012REFUSAL PROCESSED BY IB
Wednesday, April 18, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 18, 2012REFUSAL PROCESSED BY MPU
Saturday, April 14, 2012APPLICATION FILING RECEIPT MAILED
Friday, April 13, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 12, 2012NON-FINAL ACTION WRITTEN
Tuesday, April 10, 2012ASSIGNED TO EXAMINER
Tuesday, April 10, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 9, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, April 6, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

truhancis preparations substances pharmaceutical system disease nervous central treatment prevention disorders